STOCK TITAN

[Form 4] Warby Parker Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Teresa Briggs, a director of Warby Parker Inc. (WRBY), reported an insider sale on Form 4. On 08/11/2025 she sold 6,000 shares of Class A common stock at a reported price of $23.56 per share. After the sale she is shown as directly owning 44,879 shares and indirectly owning 15,969 shares held in The Teresa Briggs Trust. The filing notes she may be deemed to have voting and dispositive power over the trust shares. The form was signed by an attorney-in-fact on 08/13/2025. No other transactions or derivative positions are reported.

Teresa Briggs, una direttrice di Warby Parker Inc. (WRBY), ha segnalato una vendita da insider sul Modulo 4. In data 08/11/2025 ha venduto 6,000 azioni ordinarie di Classe A al prezzo riportato di $23.56 per azione. Dopo la vendita risulta titolare diretta di 44,879 azioni e titolare indiretta di 15,969 azioni detenute nel The Teresa Briggs Trust. La comunicazione specifica che potrebbe essere considerata in possesso del potere di voto e di disposizione sulle azioni del trust. Il modulo è stato firmato da un procuratore il 08/13/2025. Non sono riportate altre operazioni né posizioni in derivati.

Teresa Briggs, directora de Warby Parker Inc. (WRBY), informó una venta de insider en el Formulario 4. El 08/11/2025 vendió 6,000 acciones ordinarias Clase A al precio informado de $23.56 por acción. Tras la venta figura como propietaria directa de 44,879 acciones y propietaria indirecta de 15,969 acciones en The Teresa Briggs Trust. La presentación indica que podría considerarse que tiene poder de voto y de disposición sobre las acciones del fideicomiso. El formulario fue firmado por un apoderado el 08/13/2025. No se informan otras transacciones ni posiciones en derivados.

테레사 브릭스는 Warby Parker Inc. (WRBY)의 이사로서 Form 4에 내부자 매도 사실을 신고했습니다. 08/11/2025에 주당 $23.56로 보고된 가격에 클래스 A 보통주 6,000주를 매도했습니다. 매도 후 그녀는 직접적으로 44,879주를 보유하고 있으며 The Teresa Briggs Trust에 명의로 15,969주를 간접 보유하고 있는 것으로 나타납니다. 제출 서류에는 그녀가 신탁 주식에 대해 의결권 및 처분권을 갖는 것으로 간주될 수 있다고 기재되어 있습니다. 해당 양식은 대리인이 08/13/2025에 서명했습니다. 다른 거래나 파생상품 포지션은 보고되지 않았습니다.

Teresa Briggs, administratrice de Warby Parker Inc. (WRBY), a déclaré une cession d'initié sur le formulaire 4. Le 08/11/2025, elle a vendu 6,000 actions ordinaires de catégorie A au prix déclaré de $23.56 par action. Après la vente, elle apparaît comme propriétaire directe de 44,879 actions et propriétaire indirecte de 15,969 actions détenues dans The Teresa Briggs Trust. Le dossier indique qu'elle pourrait être considérée comme détenant le pouvoir de vote et de disposition sur les actions du trust. Le formulaire a été signé par un mandataire le 08/13/2025. Aucune autre transaction ni position en dérivés n'est signalée.

Teresa Briggs, Direktorin von Warby Parker Inc. (WRBY), meldete einen Insider-Verkauf im Formular 4. Am 08/11/2025 verkaufte sie 6,000 Aktien der Klasse A-Stammaktien zu einem gemeldeten Preis von $23.56 pro Aktie. Nach dem Verkauf wird sie als direkte Inhaberin von 44,879 Aktien und als indirekte Inhaberin von 15,969 Aktien ausgewiesen, die im The Teresa Briggs Trust gehalten werden. Die Einreichung weist darauf hin, dass sie als Inhaberin von Stimm- und Verfügungsgewalt über die Trust-Aktien angesehen werden könnte. Das Formular wurde am 08/13/2025 von einem Bevollmächtigten unterzeichnet. Es werden keine weiteren Transaktionen oder Derivatepositionen gemeldet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR Director Teresa Briggs sold 6,000 WRBY shares at $23.56, retaining direct and trust ownership totaling 60,848 shares.

The reported sale is a routine Section 16 disclosure showing a reported sale of 6,000 Class A shares on 08/11/2025 at $23.56. Post-transaction holdings are 44,879 direct and 15,969 indirect (via trust), for a combined beneficial position of 60,848 shares as disclosed. The filing includes an explanatory note that Ms. Briggs may exercise voting/dispositive power over trust shares. There are no derivative holdings or additional material changes disclosed.

TL;DR This Form 4 documents a director sale with continued meaningful ownership through direct and trust holdings.

The disclosure identifies Ms. Briggs as a director and indicates the sale was reported individually (one reporting person). The presence of an indirect trust holding and the explanatory note are standard governance disclosures clarifying beneficial ownership and potential voting influence. The form is signed by an attorney-in-fact, dated 08/13/2025, and contains no indication of 10% ownership or of unusual derivative activity.

Teresa Briggs, una direttrice di Warby Parker Inc. (WRBY), ha segnalato una vendita da insider sul Modulo 4. In data 08/11/2025 ha venduto 6,000 azioni ordinarie di Classe A al prezzo riportato di $23.56 per azione. Dopo la vendita risulta titolare diretta di 44,879 azioni e titolare indiretta di 15,969 azioni detenute nel The Teresa Briggs Trust. La comunicazione specifica che potrebbe essere considerata in possesso del potere di voto e di disposizione sulle azioni del trust. Il modulo è stato firmato da un procuratore il 08/13/2025. Non sono riportate altre operazioni né posizioni in derivati.

Teresa Briggs, directora de Warby Parker Inc. (WRBY), informó una venta de insider en el Formulario 4. El 08/11/2025 vendió 6,000 acciones ordinarias Clase A al precio informado de $23.56 por acción. Tras la venta figura como propietaria directa de 44,879 acciones y propietaria indirecta de 15,969 acciones en The Teresa Briggs Trust. La presentación indica que podría considerarse que tiene poder de voto y de disposición sobre las acciones del fideicomiso. El formulario fue firmado por un apoderado el 08/13/2025. No se informan otras transacciones ni posiciones en derivados.

테레사 브릭스는 Warby Parker Inc. (WRBY)의 이사로서 Form 4에 내부자 매도 사실을 신고했습니다. 08/11/2025에 주당 $23.56로 보고된 가격에 클래스 A 보통주 6,000주를 매도했습니다. 매도 후 그녀는 직접적으로 44,879주를 보유하고 있으며 The Teresa Briggs Trust에 명의로 15,969주를 간접 보유하고 있는 것으로 나타납니다. 제출 서류에는 그녀가 신탁 주식에 대해 의결권 및 처분권을 갖는 것으로 간주될 수 있다고 기재되어 있습니다. 해당 양식은 대리인이 08/13/2025에 서명했습니다. 다른 거래나 파생상품 포지션은 보고되지 않았습니다.

Teresa Briggs, administratrice de Warby Parker Inc. (WRBY), a déclaré une cession d'initié sur le formulaire 4. Le 08/11/2025, elle a vendu 6,000 actions ordinaires de catégorie A au prix déclaré de $23.56 par action. Après la vente, elle apparaît comme propriétaire directe de 44,879 actions et propriétaire indirecte de 15,969 actions détenues dans The Teresa Briggs Trust. Le dossier indique qu'elle pourrait être considérée comme détenant le pouvoir de vote et de disposition sur les actions du trust. Le formulaire a été signé par un mandataire le 08/13/2025. Aucune autre transaction ni position en dérivés n'est signalée.

Teresa Briggs, Direktorin von Warby Parker Inc. (WRBY), meldete einen Insider-Verkauf im Formular 4. Am 08/11/2025 verkaufte sie 6,000 Aktien der Klasse A-Stammaktien zu einem gemeldeten Preis von $23.56 pro Aktie. Nach dem Verkauf wird sie als direkte Inhaberin von 44,879 Aktien und als indirekte Inhaberin von 15,969 Aktien ausgewiesen, die im The Teresa Briggs Trust gehalten werden. Die Einreichung weist darauf hin, dass sie als Inhaberin von Stimm- und Verfügungsgewalt über die Trust-Aktien angesehen werden könnte. Das Formular wurde am 08/13/2025 von einem Bevollmächtigten unterzeichnet. Es werden keine weiteren Transaktionen oder Derivatepositionen gemeldet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Briggs Teresa

(Last) (First) (Middle)
C/O WARBY PARKER INC.,
233 SPRING STREET, 6TH FLOOR EAST

(Street)
NEW YORK NY 10013

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Warby Parker Inc. [ WRBY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 08/11/2025 S 6,000 D $23.56 44,879 D
Class A Common Stock 15,969 I By Trust(1)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Ms. Briggs may be deemed to have voting power and dispositive power over the shares held by The Teresa Briggs Trust.
/s/ Chris Utecht, Attorney-in-Fact 08/13/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Teresa Briggs report on Form 4 for WRBY?

The filing reports a sale of 6,000 Class A common shares on 08/11/2025 at a price of $23.56 per share.

How many WRBY shares does Teresa Briggs own after the reported transaction?

After the reported sale she directly owns 44,879 shares and indirectly owns 15,969 shares via The Teresa Briggs Trust.

What is Teresa Briggs' relationship to Warby Parker (WRBY)?

The Form 4 identifies Teresa Briggs as a Director of Warby Parker Inc.

Was the Form 4 filed by more than one reporting person?

No. The form indicates it was filed by one reporting person.

Who signed the Form 4 and when?

The form was signed by Chris Utecht, Attorney-in-Fact on 08/13/2025.
Warby Parker Inc

NYSE:WRBY

WRBY Rankings

WRBY Latest News

WRBY Latest SEC Filings

WRBY Stock Data

3.27B
97.11M
7.54%
94.36%
7.47%
Medical Instruments & Supplies
Ophthalmic Goods
Link
United States
NEW YORK